Recruiting now—Ages 18 Years to 39 Years
Early Ageing During Therapy in AYA Cancer Patients
Sponsor: University Medical Center Groningen · NCT05062707 on ClinicalTrials.gov ↗
Conditions studied
CancerLeukemiaHodgkin LymphomaTesticular CancerOsteosarcomaEwing SarcomaBreast CancerCervical Cancer
What it tests
- Blood samplingprocedure
Where it's running1 site
1 international site
- Recruiting now
University Medical Center Groningen
Groningen, Netherlands 9713 GZ
- J. Nuver, MD, PhD(contact)+31 50 361 2821[email protected]
- J. Nuver, MD, PhD(principal investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Aged 18-39 years at cancer diagnosis * Having a histologically and/or cytologically confirmed cancer diagnosis, including leukemia, (non-)Hodgkin lymphoma, testicular cancer, osteosarcoma, Ewing sarcoma, breast cancer, and cervical cancer. * Scheduled to start systemic therapy with curative intent. Allowed treatments (concurrent or sequential) are: surgery, radiotherapy, chemotherapy, antibodies. Exclusion Criteria: * patients who are not able to understand the patient information letter and informed consent form * patients who will be treated with immune checkpoint inhibitors or targeted therapy with inhibitors of angiogenesis * patients who have been treated with systemic therapy or radiotherapy for a previous malignancy (exceptions: in situ carcinoma of the cervix or uterus and adequately treated basal and squamous cell carcinoma of the skin).
Updated 2025-05-13 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.